DIAKONOS ONCOLOGY Trademark
Trademark Overview
On Friday, November 3, 2023, a trademark application was filed for DIAKONOS ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the DIAKONOS ONCOLOGY trademark a serial number of 98253483. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, October 22, 2024. This trademark is owned by Diakonos Oncology Corporation. The DIAKONOS ONCOLOGY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for human use consisting of immunotherapy agents for the treatment and prevention of cancer; vaccine preparations
Providing medical research and scientific research information in the field of oncology; medical research in the field of oncology; research and development of immunotherapy drugs
General Information
Serial Number | 98253483 |
Word Mark | DIAKONOS ONCOLOGY |
Filing Date | Friday, November 3, 2023 |
Status | 686 - PUBLISHED FOR OPPOSITION |
Status Date | Tuesday, October 22, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, October 22, 2024 |
Trademark Statements
Goods and Services | Pharmaceutical preparations for human use consisting of immunotherapy agents for the treatment and prevention of cancer; vaccine preparations |
NOT AVAILABLE | "ONCOLOGY" |
Translation of Words in Mark | The English translation of DIAKONOS in the mark is a servant, minister, or deacon. |
Goods and Services | Providing medical research and scientific research information in the field of oncology; medical research in the field of oncology; research and development of immunotherapy drugs |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, November 21, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, November 21, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Diakonos Oncology Corporation |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Houston, TX 77058 |
Party Name | Diakonos Oncology Corporation |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Houston, TX 77058 |
Trademark Events
Event Date | Event Description |
Tuesday, November 21, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, June 13, 2024 | ASSIGNED TO EXAMINER |
Monday, June 17, 2024 | NON-FINAL ACTION E-MAILED |
Monday, June 17, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, June 17, 2024 | NON-FINAL ACTION WRITTEN |
Tuesday, September 17, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, September 17, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, September 17, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, September 17, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, October 2, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, October 22, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, October 22, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, November 7, 2023 | NEW APPLICATION ENTERED |